OpenURL Connection Search

Select item for more details and to access through your institution.

Correction: Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4.
Published in:
European Journal of Immunology, 2011, v. 41, n. 5, p. 1501, doi. 10.1002/eji.201190030
By:
- Scriba, Thomas J.;
- Tameris, Michele;
- Mansoor, Nazma;
- Smit, Erica;
- van der Merwe, Linda;
- Isaacs, Fatima;
- Keyser, Alana;
- Moyo, Sizulu;
- Brittain, Nathaniel;
- Lawrie, Alison;
- Gelderbloem, Sebastian;
- Veldsman, Ashley;
- Hatherill, Mark;
- Hawkridge, Anthony;
- Hill, Adrian V. S.;
- Hussey, Gregory D.;
- Mahomed, Hassan;
- McShane, Helen;
- Hanekom, Willem A.
Publication type:
Article
Mapping the Field of Statistics Education Research in Search of Scholarship.
Published in:
International Journal for the Scholarship of Teaching & Learning, 2011, v. 5, n. 1, p. 1, doi. 10.20429/ijsotl.2011.050129
By:
- van der Merwe, Linda;
- Wilkinson, Annette
Publication type:
Article
Safety and Immunogenicity of a New Tuberculosis Vaccine, MVA85A, in Healthy Adults in South Africa.
Published in:
Journal of Infectious Diseases, 2008, v. 198, n. 4, p. 544, doi. 10.1086/590185
By:
- Hawkridge, Tony;
- Scriba, Thomas J.;
- Gelderbloem, Sebastian;
- Smit, Erica;
- Tameris, Michele;
- Moyo, Sizulu;
- Lang, Trudie;
- Veldsman, Ashley;
- Hatherill, Mark;
- van der Merwe, Linda;
- Fletcher, Helen A.;
- Mahomed, Hassan;
- Hill, Adrian V. S.;
- Hanekom, Willem A.;
- Hussey, Gregory D.;
- McShane, Helen
Publication type:
Article
A Phase Ila Trial of the New Tuberculosis Vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis-infected Adults.
Published in:
American Journal of Respiratory & Critical Care Medicine, 2012, v. 185, n. 7, p. 769, doi. 10.1164/rccm.201108-1548oc
By:
- Scriba, Thomas J.;
- Tameris, Michele;
- Smit, Erica;
- van der Merwe, Linda;
- Hughes, E. Jane;
- Kadira, Blessing;
- Mauff, Katya;
- Moyo, Sizulu;
- Brittain, Nathaniel;
- Lawrie, Alison;
- Mulenga, Humphrey;
- de Kock, Marwou;
- Makhethe, Lebohang;
- van Rensburg, Esme Janse;
- Gelderbloem, Sebastian;
- Veldsman, Ashley;
- Hatherill, Mark;
- Geldenhuys, Hendrik;
- Hill, Adrian V. S.;
- Hawkridge, Anthony
Publication type:
Article
Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4.
Published in:
European Journal of Immunology, 2010, v. 40, n. 1, p. 279, doi. 10.1002/eji.200939754
By:
- Scriba, Thomas J.;
- Tameris, Michele;
- Mansoor, Nazma;
- Smit, Erica;
- van der Merwe, Linda;
- Isaacs, Fatima;
- Keyser, Alana;
- Moyo, Sizulu;
- Brittain, Nathaniel;
- Lawrie, Alison;
- Gelderbloem, Sebastian;
- Veldsman, Ashley;
- Hatherill, Mark;
- Hawkridge, Anthony;
- Hill, Adrian V. S.;
- Hussey, Gregory D.;
- Mahomed, Hassan;
- McShane, Helen;
- Hanekom, Willem A.
Publication type:
Article

Found: 5

Correction: Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4.

Mapping the Field of Statistics Education Research in Search of Scholarship.

Safety and Immunogenicity of a New Tuberculosis Vaccine, MVA85A, in Healthy Adults in South Africa.

A Phase Ila Trial of the New Tuberculosis Vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis-infected Adults.

Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4.